India is on the brink of finalizing a free trade agreement with the European Union. Yet even as the deal gets close, one area remains hotly contested: protection for intellectual property (IP). Controversy mounts over "data exclusivity" for pharmaceuticals.

India has enormous potential for drug development if its legal system will respect intellectual property.

In the two years since its enactment, the U.S.-Chile Free Trade Agreement has gotten positive reviews from the governments of Chile and the United States. Not only has total trade increased by 85 percent, but decreased tariffs have stimulated increased diversity of goods. The good news is due, at least...

This new volume from the AEI Press includes six thoughtful essays on the intellectual property controversy in two of today’s key knowledge-based industries.

The saber rattling has to stop or the current deliverers ofHIV drugswill have left the business.

In this volume, leading scholars tackle the debate over intellectual property rights in high-technology industries and express their views on how to improve the current system.

Many of the critics of the Stop Online Piracy Act (SOPA), and other legislation seeking to combat intellectual property violations on the Internet, say they are fighting efforts to “censor” the web. SOPA is many things, but if words still have meaning it cannot be fruitfully described as censorship.

This paper discusses a number of issues in the context of the debate on intellectual property in less developed countries.